https://www.thebodypro.com/category/fda-approved-hiv-medications

FDA-Approved HIV Medications

The Latest

Starting Treatment With First-Line Protease Inhibitors May Increase Kidney Disease Risk Img
Kidney

Starting Treatment With First-Line Protease Inhibitors May Increase Kidney Disease Risk

Starting antiretroviral therapy with a ritonavir (Norvir)-boosted protease inhibitor resulted in a higher incidence of chronic kidney disease (CKD), whether or not the regimen included tenofovir disoproxil fumarate (TDF, Viread), according to a recen...

Doravirine Can Be Co-Administered With Oral Contraceptives Img

Doravirine Can Be Co-Administered With Oral Contraceptives

Multiple dosing with doravirine does not change the plasma pharmacokinetics of a single dose of ethinyl estradiol or levonorgestrel to a clinically important extent, according to data shown at the 6th International Workshop on HIV and Women.

Doctors Report Interaction Between Cobicistat and Tacrolimus Img
News

Doctors Report Interaction Between Cobicistat and Tacrolimus

A team in Chicago recently reported an interaction between cobicistat and the transplant medicine tacrolimus (Advagraf, Prograf) in a person taking Stribild, and cautioned others to be mindful of the potential for interaction between these drugs.

Taking Darunavir/Cobicistat With Novel Attachment Inhibitor BMS-663068 Is Safe Img
Conference Coverage

Taking Darunavir/Cobicistat With Novel Attachment Inhibitor BMS-663068 Is Safe

Taking darunavir/cobicistat (Prezcobix) with a new HIV drug known as BMS-663068, which is currently being studied, was safe and did not cause any serious reactions in two studies.

Protease Inhibitor Combinations Work Best With at Least 95% On-Time Pill Taking Img

Protease Inhibitor Combinations Work Best With at Least 95% On-Time Pill Taking

Antiretroviral combinations including a protease inhibitor led to undetectable viral loads more often when people took their pills on time at least 95% of the time than when they took their pills less often.

Promo Image
IDWeek

What's Hot in HIV Clinical Science

What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.

Unintended Pregnancies With Levonorgestrel Implant Due to Drug Interactions With Efavirenz-Based Antiretroviral Therapy Img
Conference Coverage

Unintended Pregnancies With Levonorgestrel Implant Due to Drug Interactions With Efavirenz-Based Antiretroviral Therapy

Three unintended pregnancies in women with levonorgestrel sub-dermal implants, receiving efavirenz-based antiretroviral therapy in a pharmacokinetic study, were reported in a late breaker presentation at CROI 2015.

Promo Image
IDWeek

What 2014 Development Has the Biggest Impact on HIV Care?

Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …

Promo Image
IDWeek

HIV Drug Development Pipeline Update, Fall 2014 Edition

HIV treatment remains far from perfect, and there are still seats at the table available for improved antiretrovirals. Paul Sax, M.D., provides an update on several of the most noteworthy candidates currently in development.

Promo Image
IDWeek

What's Hot in HIV Treatment

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.